Valuation Boston Scientific Corporation

Equities

Real-time Estimate Cboe BZX Other stock markets 19:57:45 13/03/2026 GMT			5-day change	1st Jan Change
69.18 ^USD	+0.92%		-3.43%	-27.74%

03:34pm	Abbott Laboratories' Structural Heart Business Could See Upside From Watchman Trial Results, UBS Says	MT
03-11	Citigroup Adjusts Price Target on Boston Scientific to $94 From $102, Maintains Buy Rating	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	60,534	66,273	84,691	131,642	141,351	101,720	-	-
Change	-	9.48%	27.79%	55.44%	7.37%	-28.04%	-	-
Enterprise Value (EV) ¹	67,674	74,280	92,928	141,974	150,822	107,458	104,510	101,370
Change	-	9.76%	25.1%	52.78%	6.23%	-28.75%	-2.74%	-3%
P/E ratio	61.6x	103x	54x	71.5x	49.1x	28x	23.4x	19.2x
PBR	3.64x	3.77x	4.39x	6.05x	5.84x	3.61x	3.16x	2.83x
PEG	-	-3x	0x	4.3x	0.9x	1.1x	1.2x	0.9x
Capitalization / Revenue	5.09x	5.23x	5.95x	7.86x	7.04x	4.56x	4.14x	3.76x
EV / Revenue	5.69x	5.86x	6.53x	8.48x	7.51x	4.82x	4.25x	3.75x
EV / EBITDA	16.5x	20.8x	22.6x	29.3x	-	15.6x	13.5x	11.6x
EV / EBIT	22.5x	22.9x	24.9x	31.3x	26.9x	16.9x	14.7x	12.7x
EV / FCF	51.4x	79.2x	51.9x	53.7x	41.2x	31.8x	26.1x	18.9x
FCF Yield	1.94%	1.26%	1.93%	1.86%	2.43%	3.14%	3.83%	5.3%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	0.69	0.45	1.07	1.25	1.94	2.448	2.929	3.566
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	11,888	12,682	14,240	16,747	20,074	22,283	24,582	27,022
EBITDA ¹	4,103	3,574	4,106	4,839	-	6,890	7,735	8,759
EBIT ¹	3,010	3,241	3,738	4,529	5,612	6,354	7,115	7,961
Net income ¹	985	642	1,570	1,853	2,898	3,599	4,303	5,171
Net Debt ¹	7,140	8,007	8,237	10,332	9,471	5,737	2,790	-350.6
Reference price ²	42.48	46.27	57.81	89.32	95.35	68.55	68.55	68.55
Nbr of stocks (in thousands)	1,424,992	1,432,311	1,464,983	1,473,827	1,482,442	1,483,885	-	-
Announcement Date	02/02/22	01/02/23	31/01/24	05/02/25	04/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
BOSTON SCIENTIFIC CORPORATION	28.01x	4.82x	15.6x	-.--%	102B
THERMO FISHER SCIENTIFIC, INC.	24.4x	4.32x	16.91x	0.39%	177B
INTUITIVE SURGICAL, INC.	54.24x	14.03x	32.64x	-.--%	170B
DANAHER CORPORATION	29.1x	5.53x	17.32x	0.71%	132B
SIEMENS HEALTHINEERS AG	19.68x	2.31x	11.47x	2.69%	50.2B
EDWARDS LIFESCIENCES CORPORATION	29.36x	6.69x	21.48x	-.--%	49.14B
RESMED, INC.	21.97x	5.78x	14.85x	1.05%	33.71B
GE HEALTHCARE TECHNOLOGIES INC.	14.55x	1.67x	9.01x	0.23%	32.05B
AGILENT TECHNOLOGIES, INC.	21.41x	4.4x	15.23x	0.92%	31.55B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	22.5x	5.7x	16.25x	2.94%	31.37B
Average	26.52x	5.53x	17.08x	0.89%	80.84B
Weighted average by Cap.	31.23x	6.66x	19.57x	0.57%